Smilagenin acetate |
| Catalog No.GC61282 |
Smilagenin acetate is a sapogenin derivative extracted from patent US20030004147A1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 4947-75-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Smilagenin acetate is a Sapogenin derivative extracted from patent US20030004147A1. Smilagenin acetate increases the expression of acetylcholine m2 receptors and can be used for the research of dementia[1].
Smilagenin acetate increases the expression of m2 receptors on CHO cells transfected with DNA for the m2 receptor[1].
[1]. Paul Barraclough, et al. 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia. US20030004147A1.
Average Rating: 5 (Based on Reviews and 3 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *